Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Rates, Predictors, and Outcomes of Ustekinumab Dose Escalation in Inflammatory Bowel Disease
Publication Year: 2025 Source: J Clin Gastroenterol PMID: 38595134 DOI: 10.1097/MCG.0000000000002003
OBJECTIVE: Ustekinumab (UST) is effective for the induction and maintenance of remission in inflammatory bowel disease (IBD). However, a significant proportion of patients will require UST dose escalation. We sought to determine the rates, predictors, and outcomes of UST dose escalation in patients with IBD. PATIENTS AND METHODS: This was …
Clinical effectiveness and safety of ustekinumab in youth with refractory inflammatory bowel disease: A retrospective cohort study
Publication Year: 2025 Source: Saudi J Gastroenterol PMID: 38597337 DOI: 10.4103/sjg.sjg_7_24
BACKGROUND: Inflammatory bowel disease (IBD) incidence and prevalence has been increasing worldwide. Limited data exists on the effectiveness of ustekinumab (UST) in children. We aimed to describe the effectiveness and safety of UST in pediatric patients with IBD. METHODS: A single-center retrospective study was conducted between January 2017 and February …
Changes Over Time in the Lémann Index and the Inflammatory Bowel Disease Disability Index in a Prospective Cohort of Patients With Crohn's Disease
Publication Year: 2025 Source: Inflamm Bowel Dis PMID: 38597799 DOI: 10.1093/ibd/izae073
BACKGROUND: Crohn's disease (CD) is a progressive, destructive, and disabling disorder. Our study aimed to assess changes over time in the Lemann index (LI) and the Inflammatory Bowel Disease Disability Index (IBD-DI) in a cohort of CD patients. METHODS: This was a single-center prospective cohort study of 130 consecutive CD …
Periodontitis increases the risk of gastrointestinal dysfunction: an update on the plausible pathogenic molecular mechanisms
Publication Year: 2025 Source: Crit Rev Microbiol PMID: 38602474
No Abstract
Long-term mental and physical quality of life outcomes following ileal pouch anal anastomosis surgery
Publication Year: 2025 Source: Ann R Coll Surg Engl PMID: 38362797 DOI: 10.1308/rcsann.2023.0075
INTRODUCTION: This study presents the authors' experience over 14 years of performing restorative procto-colectomy with ileal pouch anal anastomosis (IPAA). The aim was to study the long-term quality of life outcomes and analyse the predictors of pouch function as well as physical and mental wellbeing. METHODS: This is a single-centre …
Ultra-processed food consumption and human health: an umbrella review of systematic reviews with meta-analyses
Publication Year: 2025 Source: Crit Rev Food Sci Nutr PMID: 38363072
No Abstract
Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study
Publication Year: 2025 Source: Intest Res PMID: 38373704 DOI: 10.5217/ir.2023.00078
BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) is a common disease with severe inflammatory processes associated with numerous gastrointestinal diseases, such as inflammatory bowel disease (IBD). Therefore, we investigated the relationship between NAFLD and IBD and the possible risk factors associated with the diagnosis of IBD. METHODS: This longitudinal nationwide cohort …
Risk of tuberculosis with anti-TNF therapy in Indian patients with inflammatory bowel disease despite negative screening
Publication Year: 2025 Source: Arab J Gastroenterol PMID: 38383265 DOI: 10.1016/j.ajg.2024.01.013
BACKGROUND AND STUDY AIMS: Tuberculosis (TB) is a well-recognized adverse effect associated with using biological therapy to manage various autoimmune conditions. There is a dearth of information about the development of TB after using anti-TNF agents in patients with inflammatory bowel disease (IBD) from TB-endemic countries like India. This study …
Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetings
Publication Year: 2025 Source: Rheumatology (Oxford) PMID: 38391112 DOI: 10.1093/rheumatology/keae116
OBJECTIVES: To assess the impact on patient outcomes of the spondyloarthritis (SpA) and inflammatory bowel disease (IBD) multidisciplinary team (MDT) meetings in a large university hospital. METHODS: A single-centre retrospective observational case-note review was conducted assessing the outcome of all 226 cases discussed at the SpA-IBD MDT meetings in a …
The role of IL-19, IL-24, IL-21 and IL-33 in intestinal mucosa of inflammatory bowel disease: A narrative review
Publication Year: 2025 Source: Arab J Gastroenterol PMID: 38395629 DOI: 10.1016/j.ajg.2024.01.002
Interleukins are potential therapeutic targets that can alter the prognosis and progression of inflammatory bowel disease (IBD). The roles of IL-6, IL-10, IL-17, and IL-23 have been extensively studied, setting the stage for the development of novel treatments for patients with IBD. Other cytokines have been less extensively studied. Members …
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide